-
Price Momentum
CNSY is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of CNSY shares has decreased $0.04 since the market last closed. This is a 1.13% drop.
-
Opened at $3.03.
The stock opened $0.06 lower than its previous close.
Key terms
About CNSY
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
-
Market cap: $23.41M
A market capitalization up to $300 million places CNSY in the micro-capitalization category.
Key terms
Smart score
Latest CNSY news
No recent TipRanks articles are available for CNSY
CNSY Financials
-
Total revenue: $5.21M (1Y), $411.00K (Q2)
Total Revenue decreased 10.49% since last year and decreased 60.02% since last quarter.
-
Net income: -$22.39M (1Y), -$9.01M (Q2)
Net Income decreased 72.49% since last year and decreased 29.66% since last quarter.
-
Earnings per share: -$7.19 (1Y), -$1.31 (Q2)
EPS increased 87.71% since last year and decreased 24.89% since last quarter.
Key terms
CNSY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CNSY Competitors
-
How competitors are chosen
CNSY's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $23.41M
A market capitalization up to $300 million places CNSY in the micro-capitalization category.
Key terms
Latest investing news
-
Bond market takes a breather after surprise move by Treasury Department -
Global bond markets are getting hammered. Here’s why that could make your life more expensive -
‘Brazen act of self-dealing.’ Lawmakers, watchdogs alarmed after Trump regulators let Trump firm start a bank -
The S&P 500 is back at a record high and the Dow just hit 54,000
